DadFinStart your free week
DadFin › Stocks › Consumer Defensive › ACU

Acme United Corporation (ACU) stock score

Consumer Defensive · Household & Personal Products · United States

$62.15 ▲ +0.34% today

71.3
Dad Score, out of 100
good

Acme United Corporation (ACU) is a Household & Personal Products company in the Consumer Defensive sector, listed in the United States. On DadFin's weekly run it scores 71.3 out of 100 on the Dad Score, a good reading that places the business ahead of 71% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Consumer Defensive it ranks #59 of 232. Its strongest axes are growth, price action and risk; its weakest are valuation and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Average
Growth
Above average
Price action
Strong
Risk
Strong
Conviction
Below average
Liquidity
Weak
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)26.7×
P/E (forward)28.3×
Dividend yield1.02%
Return on capital9.9%
Operating margin10.9%
Revenue growth (YoY)+1.0%
FCF yield2.9%
Net debt / EBITDA1.54×
Piotroski F-Score6 / 9
52-week change+60.9%
Market cap$243M
Next earningsOct 21, 2026

What subscribers see on ACU

Start your free weekSubscriber? Open the full research →

Household & Personal Products peers

StockCompanyDad ScoreBandMarket cap
PGThe Procter & Gamble Company46.1middling$336.8B
ULUnilever PLC34.5weak$128.6B
CLColgate-Palmolive Company26.7weak$67.2B
ELThe Estée Lauder Companies Inc.53.8middling$33.3B
KVUEKenvue Inc.53.1middling$33.0B
KMBKimberly-Clark Corporation21.9weak$31.3B
CHDChurch & Dwight Co., Inc.59.6middling$22.4B
CLXThe Clorox Company8.9poor$9.7B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.